Menu
 
Research menu
Jump to menu

Publications:  Dr Angray Kang

Li J, Wang J, Kang AS, Sacitharan PK(2020). Mapping the T cell response to COVID-19. Signal Transduction and Targeted Therapy vol. 5, (1)
10.1038/s41392-020-00228-1
Baker D, Amor S, Kang AS, Schmierer K, Giovannoni G(2020). The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic. Multiple Sclerosis and Related Disorders vol. 43,
10.1016/j.msard.2020.102174
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64431
Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S et al.(2020). Detecting and predicting neutralization of alemtuzumab responses in MS. Neurology(R) neuroimmunology & neuroinflammation vol. 7, (4)
10.1212/NXI.0000000000000767
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65277
Houacine S, Kang A, Parkinson EK, Wan H, Fortune F(2020). Induction of p53 in keratinocyte cultures treated with Behçet's patient sera. Journal of Oral Pathology and Medicine vol. 49, (5) 435-442.
10.1111/jop.13005
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65413
Jiang Y, Yi C, Yi Y, Jin Q, Kang AS, Li J, Kumar Sacitharan P(2020). Adiponectin exacerbates influenza infection in elderly individuals via IL-18. Signal Transduct Target Ther vol. 5, (1)
10.1038/s41392-020-0141-y
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64581
Ali L, SAXENA G, Jones M, Leisegang G, Gammon L, Gnanapavan S, Giovannoni G, Schmierer K et al.(2020). A cell-based assay for the detection of neutralizing antibodies against alemtuzumab. BioTechniques: the journal of laboratory technology for bioresearch
10.2144/btn-2019-0122
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62960
Baker D, Ali L, SAXENA G, Pryce G, Jones M, Schmierer K, Giovannoni G, Gnanapavan S et al.(2020). The irony of humanization: Alemtuzumab the first, but one of the most immunogenic, humanized monoclonal antibodies. Frontiers in Immunology vol. 11, (124)
10.3389/fimmu.2020.00124
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62968
Saxena GK, Theocharopoulos I, Aziz NT, Jones M, Gnanapavan S, Giovannoni G, Schmierer K, Garnett JA et al.(2020). GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains. Scientific Reports vol. 10, (1) Article 1860,
10.1038/s41598-020-58041-3
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62684
Uttagomol J, Ahmad US, Rehman A, Huang Y, Laly AC, Kang A, Soetaert J, Chance R et al.(2019). Evidence for the desmosomal cadherin desmoglein-3 in regulating YAP and Phospho-YAP in keratinocyte responses to mechanical forces. International Journal of Molecular Sciences vol. 20, (24)
10.3390/ijms20246221
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65251
Rehman A, Cai Y, Hünefeld C, Jedli¿ková H, Huang Y, Teck Teh M, Sharif Ahmad U, Uttagomol J et al.(2019). The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53. Cell Death and Disease vol. 10, (10)
10.1038/s41419-019-1988-0
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63718
Dubuisson N, Baker D, Kang AS, Pryce G, Marta M, Visser LH, Hofmann WE, Gnanapavan S et al.(2018). Alemtuzumab depletion failure can occur in multiple sclerosis. Immunology vol. 154, (2) 253-260.
10.1111/imm.12879
https://qmro.qmul.ac.uk/xmlui/handle/123456789/31849
Baker D, Kang AS, Gnanapavan S, Giovannoni G, Schmierer K (2017). A central role of B cells in MS control and causing autoimmunity after alemtuzumab. MULTIPLE SCLEROSIS JOURNAL. vol. 23, 336-336.
Sylejmani G, Gupta A, Cheng Q, Kang A, Durvasula R, Hurwitz I (2014). DEVELOPMENT OF RECOMBINANT ANTIBODIES TO COMBAT CLOSTRIDIUM DIFFICILE INFECTION. JOURNAL OF INVESTIGATIVE MEDICINE. vol. 62, 229-229.
Tang J, Wang L, Markiv A, Jeffs SA, Dreja H, McKnight A, He M, Kang AS(2012). Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display. Human Antibodies vol. 21, (1-2) 1-11.
10.3233/HAB-2011-0257
Ujor VC, Peiris DG, Monti M, Kang AS, Clements MO, Hedger JN(2012). Quantitative proteomic analysis of the response of the wood-rot fungus, Schizophyllum commune, to the biocontrol fungus, Trichoderma viride. Lett Appl Microbiol vol. 54, (4) 336-343.
10.1111/j.1472-765X.2012.03215.x
Azizi A, Arora A, Markiv A, Lampe DJ, Miller TA, Kang AS(2012). Ribosome Display of Combinatorial Antibody Libraries Derived from Mice Immunized with Heat-Killed Xylella fastidiosa and the Selection of MopB-Specific Single-Chain Antibodies. APPLIED AND ENVIRONMENTAL MICROBIOLOGY vol. 78, (8) 2638-2647.
10.1128/AEM.07807-11
Hurwitz I, Fieck A, Klein N, Jose C, Kang A, Durvasula R(2012). A paratransgenic strategy for the control of chagas disease. Psyche (London)
10.1155/2012/178930
Markiv A, Beatson R, Burchell J, Durvasula RV, Kang AS(2011). Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm. BMC Biotechnol vol. 11,
10.1186/1472-6750-11-117
https://qmro.qmul.ac.uk/xmlui/handle/123456789/4701
Jacobs-Lorena M, Wang S, Lampe D, Fang W, Vega-Rodriguez J, Ghosh A, Kang A, Leger RS (2011). Fighting malaria with engineered fungi and bacteria. TROPICAL MEDICINE & INTERNATIONAL HEALTH. vol. 16, 9-+.
Tsimon M, Kang A, Markiv A, Kousparou C, Epenetos A(2011). Intracellular delivery of therapeutic siRNA via an antennapedia-RNA-binding domain fusion peptide. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-4441
Fang W, Vega-Rodríguez J, Ghosh AK, Jacobs-Lorena M, Kang A, St Leger RJ(2011). Development of transgenic fungi that kill human malaria parasites in mosquitoes. Science vol. 331, (6020) 1074-1077.
10.1126/science.1199115
Markiv A, Anani B, Durvasula RV, Kang AS(2011). Module based antibody engineering: a novel synthetic REDantibody. J Immunol Methods vol. 364, (1-2) 40-49.
10.1016/j.jim.2010.10.009
Hurwitz I, Fieck A, Read A, Hillesland H, Klein N, Kang A, Durvasula R(2011). Paratransgenic control of vector borne diseases. Int J Biol Sci vol. 7, (9) 1334-1344.
10.7150/ijbs.7.1334
Damiani C, Ricci I, Crotti E, Rossi P, Rizzi A, Scuppa P, Capone A, Ulissi U et al.(2010). Mosquito-bacteria symbiosis: the case of Anopheles gambiae and Asaia. Microb Ecol vol. 60, (3) 644-654.
10.1007/s00248-010-9704-8
Fieck A, Hurwitz I, Kang AS, Durvasula R(2010). Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts. Exp Parasitol vol. 125, (4) 342-347.
10.1016/j.exppara.2010.02.016
Nguyen TV, Sacci JB, de la Vega P, John CC, James AA, Kang AS(2009). Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals. Malar J vol. 8,
10.1186/1475-2875-8-235
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7936
Return to top